Literature DB >> 18423269

Inhibition of oral mucosal cell wound healing by bisphosphonates.

Regina Landesberg1, Matthew Cozin, Serge Cremers, Victoria Woo, Stavroula Kousteni, Satrajit Sinha, LeeAnn Garrett-Sinha, Srikala Raghavan.   

Abstract

PURPOSE: Bisphosphonates (BPs) are a widely used class of drugs that are effective in the treatment and prevention of osteoporosis, hypercalcemia of malignancy, and bone metastases associated with multiple myeloma, breast cancer, and other solid tumors. In the past several years there have been numerous reports describing the occurrence of osteonecrosis of the jaws (ONJ) associated with these drugs. Whether the ONJ lesion initiates in the oral mucosa or derives from the underlying bone is not well understood. In this report we describe the effect of pamidronate, a second-generation BP, on oral mucosal cells.
MATERIALS AND METHODS: Murine oral keratinocytes were isolated and exposed to pamidronate at a range of clinically relevant doses. Cellular proliferation was measured using a MTS/PMS reagent-based kit and wound healing was examined with a scratch assay. To determine whether oral keratinocytes undergo apoptosis following exposure to pamidronate, TUNEL, caspase-3, and DAPI apoptosis assays were performed.
RESULTS: We show that BP pretreatment of oral mucosal cells inhibits proliferation and wound healing at clinically relevant doses, and that this inhibition is not due to cellular apoptosis.
CONCLUSIONS: To our knowledge this is the first report investigating the effect of nitrogen-containing BPs on oral mucosal cells. This study suggests that BPs inhibit oral keratinocyte wound healing which may play a significant role in the initiation of ONJ.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18423269      PMCID: PMC2426967          DOI: 10.1016/j.joms.2008.01.026

Source DB:  PubMed          Journal:  J Oral Maxillofac Surg        ISSN: 0278-2391            Impact factor:   1.895


  34 in total

1.  Bisphosphanates and oral cavity avascular bone necrosis.

Authors:  Cesar A Migliorati
Journal:  J Clin Oncol       Date:  2003-11-15       Impact factor: 44.544

Review 2.  Apoptosis in normal and diseased oral tissues.

Authors:  Ll Loro; O K Vintermyr; A C Johannessen
Journal:  Oral Dis       Date:  2005-09       Impact factor: 3.511

Review 3.  Screening and detection of apoptosis.

Authors:  Sergio Huerta; Emily J Goulet; Sara Huerta-Yepez; Edward H Livingston
Journal:  J Surg Res       Date:  2007-01-25       Impact factor: 2.192

4.  Pamidronate induces modifications of circulating angiogenetic factors in cancer patients.

Authors:  Daniele Santini; Bruno Vincenzi; Giuseppe Avvisati; Giordano Dicuonzo; Fabrizio Battistoni; Michele Gavasci; Alfredo Salerno; Vincenzo Denaro; Giuseppe Tonini
Journal:  Clin Cancer Res       Date:  2002-05       Impact factor: 12.531

5.  Skeletal retention of bisphosphonate (pamidronate) and its relation to the rate of bone resorption in patients with breast cancer and bone metastases.

Authors:  Serge C L M Cremers; Socrates E Papapoulos; Hans Gelderblom; Caroline Seynaeve; Jan den Hartigh; Pieter Vermeij; Carin C D van der Rijt; Lia van Zuylen
Journal:  J Bone Miner Res       Date:  2005-05-31       Impact factor: 6.741

6.  A novel non-containing-nitrogen bisphosphonate inhibits both in vitro and in vivo angiogenesis.

Authors:  Yamina Hamma-Kourbali; Mélanie Di Benedetto; Dominique Ledoux; Olivier Oudar; Yves Leroux; Marc Lecouvey; Michel Kraemer
Journal:  Biochem Biophys Res Commun       Date:  2003-10-24       Impact factor: 3.575

7.  Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research.

Authors:  Sundeep Khosla; David Burr; Jane Cauley; David W Dempster; Peter R Ebeling; Dieter Felsenberg; Robert F Gagel; Vincente Gilsanz; Theresa Guise; Sreenivas Koka; Laurie K McCauley; Joan McGowan; Marc D McKee; Suresh Mohla; David G Pendrys; Lawrence G Raisz; Salvatore L Ruggiero; David M Shafer; Lillian Shum; Stuart L Silverman; Catherine H Van Poznak; Nelson Watts; Sook-Bin Woo; Elizabeth Shane
Journal:  J Bone Miner Res       Date:  2007-10       Impact factor: 6.741

8.  A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma.

Authors:  Fred Saad; Donald M Gleason; Robin Murray; Simon Tchekmedyian; Peter Venner; Louis Lacombe; Joseph L Chin; Jeferson J Vinholes; J Allen Goas; Bee Chen
Journal:  J Natl Cancer Inst       Date:  2002-10-02       Impact factor: 13.506

9.  American Society of Clinical Oncology 2007 clinical practice guideline update on the role of bisphosphonates in multiple myeloma.

Authors:  Robert A Kyle; Gary C Yee; Mark R Somerfield; Patrick J Flynn; Susan Halabi; Sundar Jagannath; Robert Z Orlowski; David G Roodman; Patricia Twilde; Kenneth Anderson
Journal:  J Clin Oncol       Date:  2007-05-21       Impact factor: 44.544

10.  The pharmacokinetics and distribution of pamidronate for a range of doses in the mouse.

Authors:  C R Hoggarth; R Bennett; P T Daley-Yates
Journal:  Calcif Tissue Int       Date:  1991-12       Impact factor: 4.333

View more
  72 in total

1.  Osteonecrosis and atypical fractures-common origins?

Authors:  G Subramanian; J C Fritton; S Y P Quek
Journal:  Osteoporos Int       Date:  2012-03-10       Impact factor: 4.507

Review 2.  A systematic review of bisphosphonate osteonecrosis (BON) in cancer.

Authors:  Cesar Augusto Migliorati; Sook-Bin Woo; Ian Hewson; Andrei Barasch; Linda S Elting; Fred K L Spijkervet; Michael T Brennan
Journal:  Support Care Cancer       Date:  2010-04-22       Impact factor: 3.603

3.  Bisphosphonates induce senescence in normal human oral keratinocytes.

Authors:  R H Kim; R S Lee; D Williams; S Bae; J Woo; M Lieberman; J-E Oh; Q Dong; K-H Shin; M K Kang; N-H Park
Journal:  J Dent Res       Date:  2011-03-22       Impact factor: 6.116

4.  Bisphosphonate-related osteonecrosis of the jaw: position paper from the Allied Task Force Committee of Japanese Society for Bone and Mineral Research, Japan Osteoporosis Society, Japanese Society of Periodontology, Japanese Society for Oral and Maxillofacial Radiology, and Japanese Society of Oral and Maxillofacial Surgeons.

Authors:  Toshiyuki Yoneda; Hiroshi Hagino; Toshitsugu Sugimoto; Hiroaki Ohta; Shunji Takahashi; Satoshi Soen; Akira Taguchi; Satoru Toyosawa; Toshihiko Nagata; Masahiro Urade
Journal:  J Bone Miner Metab       Date:  2010-03-24       Impact factor: 2.626

5.  New evidence on bisphosphonate related osteonecrosis of the jaws suggests dental referral prior to commencement of treatment.

Authors:  A Kyrgidis; St Triaridis; K Vahtsevanos
Journal:  Hippokratia       Date:  2009-01       Impact factor: 0.471

6.  Importance of microcracks in etiology of bisphosphonate-related osteonecrosis of the jaw: a possible pathogenetic model of symptomatic and non-symptomatic osteonecrosis of the jaw based on scanning electron microscopy findings.

Authors:  Sebastian Hoefert; Inge Schmitz; Andrea Tannapfel; Harald Eufinger
Journal:  Clin Oral Investig       Date:  2009-06-18       Impact factor: 3.573

7.  Salivary proteomics in bisphosphonate-related osteonecrosis of the jaw.

Authors:  V Thumbigere-Math; B S Michalowicz; E P de Jong; T J Griffin; D L Basi; P J Hughes; M L Tsai; K K Swenson; L Rockwell; R Gopalakrishnan
Journal:  Oral Dis       Date:  2013-11-29       Impact factor: 3.511

8.  Influence of bisphosphonates on endothelial cells, fibroblasts, and osteogenic cells.

Authors:  C Walter; M O Klein; A Pabst; B Al-Nawas; H Duschner; T Ziebart
Journal:  Clin Oral Investig       Date:  2009-03-18       Impact factor: 3.573

9.  Low-level laser therapy for osteonecrotic lesions: effects on osteoblasts treated with zoledronic acid.

Authors:  Fernanda Gonçalves Basso; Ana Paula Silveira Turrioni; Diana Gabiela Soares; Vanderlei Salvador Bagnato; Josimeri Hebling; Carlos Alberto de Souza Costa
Journal:  Support Care Cancer       Date:  2014-05-07       Impact factor: 3.603

10.  Population pharmacokinetic and pharmacodynamic modeling for assessing risk of bisphosphonate-related osteonecrosis of the jaw.

Authors:  Parish P Sedghizadeh; Allan C Jones; Chris LaVallee; Roger W Jelliffe; Anh D Le; Peter Lee; Andrew Kiss; Michael Neely
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2012-12-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.